INNOVIVA, INC. Increase (Decrease) in Accrued Liabilities
INNOVIVA, INC. (INVA) reported Increase (Decrease) in Accrued Liabilities of -$2.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-05
- INNOVIVA, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $7.64M, a 13.38% increase year-over-year.
- INNOVIVA, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$9.80M.
- INNOVIVA, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $8.78M, a 25.02% increase year-over-year.
- INNOVIVA, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$16.50M, a 936.29% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$5.79M, a 290.21% decline from fiscal 2024.
- INNOVIVA, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $3.04M.
- INNOVIVA, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$1.50M, a 112.57% decline from fiscal 2022.
- INNOVIVA, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $11.91M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $7.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.15M 10-Q · filed 2026-08-05 | $6.62M derived: sum of 3 quarters · filed 2026-08-05 | -$9.88M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$9.80M 10-Q · filed 2026-05-06 | -$1.02M derived: sum of 2 quarters · filed 2026-05-06 | -$17.52M derived: sum of 3 quarters · filed 2026-05-06 | -$10.78M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$7.72M derived: sum of 2 quarters · filed 2026-02-25 | -$981.00K derived: sum of 3 quarters · filed 2026-08-05 | -$5.79M 10-K · filed 2026-02-25 | |
| 2025-09-30 | -$16.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$9.76M derived: sum of 2 quarters · filed 2026-08-05 | -$14.57M 10-Q · filed 2025-11-05 | -$7.55M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $6.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.93M 10-Q · filed 2026-08-05 | $8.95M derived: sum of 3 quarters · filed 2026-08-05 | $10.93M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$4.81M 10-Q · filed 2026-05-06 | $2.21M derived: sum of 2 quarters · filed 2026-05-06 | $4.18M derived: sum of 3 quarters · filed 2026-05-06 | -$2.21M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $7.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.99M derived: sum of 2 quarters · filed 2026-02-25 | $2.60M derived: sum of 3 quarters · filed 2026-02-25 | $3.04M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$4.42M derived: sum of 2 quarters · filed 2025-11-05 | -$3.98M 10-Q · filed 2025-11-05 | -$4.40M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | -$6.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$5.95M 10-Q · filed 2025-08-06 | -$6.38M derived: sum of 3 quarters · filed 2026-02-25 | -$4.19M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $441.00K 10-Q · filed 2025-05-07 | $15.00K derived: sum of 2 quarters · filed 2026-02-25 | $2.20M derived: sum of 3 quarters · filed 2026-02-25 | -$492.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | -$426.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.76M derived: sum of 2 quarters · filed 2026-02-25 | -$933.00K derived: sum of 3 quarters · filed 2026-02-25 | -$1.50M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$507.00K derived: sum of 2 quarters · filed 2024-11-06 | -$1.07M 10-Q · filed 2024-11-06 | $12.55M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | -$2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$3.26M 10-Q · filed 2024-07-31 | $10.36M derived: sum of 3 quarters · filed 2025-02-26 | $1.71M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | -$565.00K 10-Q · filed 2024-05-08 | $13.06M derived: sum of 2 quarters · filed 2025-02-26 | $4.41M derived: sum of 3 quarters · filed 2025-02-26 | $9.23M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $13.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $4.97M derived: sum of 2 quarters · filed 2025-02-26 | $9.80M derived: sum of 3 quarters · filed 2025-02-26 | $11.91M 10-K · filed 2025-02-26 | |
| 2022-09-30 | -$8.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$3.83M derived: sum of 2 quarters · filed 2023-11-01 | -$1.71M 10-Q · filed 2023-11-01 | -$1.43M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | $4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $6.94M 10-Q · filed 2023-08-02 | $7.21M derived: sum of 3 quarters · filed 2024-03-05 | $7.39M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | $2.12M 10-Q · filed 2023-05-09 | $2.39M derived: sum of 2 quarters · filed 2024-03-05 | $2.57M derived: sum of 3 quarters · filed 2024-03-05 | $1.63M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | $276.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | $452.00K derived: sum of 2 quarters · filed 2024-03-05 | -$484.00K derived: sum of 3 quarters · filed 2024-03-05 | -$257.00K 10-K/A · filed 2024-03-05 | |
| 2021-09-30 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$760.00K derived: sum of 2 quarters · filed 2022-11-09 | -$533.00K 10-Q · filed 2022-11-09 | $19.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | -$936.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$709.00K 10-Q · filed 2022-07-27 | -$157.00K derived: sum of 3 quarters · filed 2023-02-28 | $110.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $227.00K 10-Q · filed 2022-05-05 | $779.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.05M derived: sum of 3 quarters · filed 2023-02-28 | $1.16M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $552.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $819.00K derived: sum of 2 quarters · filed 2023-02-28 | $930.00K derived: sum of 3 quarters · filed 2023-02-28 | $804.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $267.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $378.00K derived: sum of 2 quarters · filed 2021-10-27 | $252.00K 10-Q · filed 2021-10-27 | -$294.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2020-06-30 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$15.00K 10-Q · filed 2021-07-29 | -$561.00K derived: sum of 3 quarters · filed 2022-03-17 | -$797.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2020-03-31 | -$126.00K 10-Q · filed 2021-04-28 | -$672.00K derived: sum of 2 quarters · filed 2022-03-17 | -$908.00K derived: sum of 3 quarters · filed 2022-03-17 | -$731.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2019-12-31 | -$546.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | -$782.00K derived: sum of 2 quarters · filed 2022-03-17 | -$605.00K derived: sum of 3 quarters · filed 2022-03-17 | -$439.00K 10-K/A · filed 2022-03-17 | |
| 2019-09-30 | -$236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$59.00K derived: sum of 2 quarters · filed 2020-10-28 | $107.00K 10-Q · filed 2020-10-28 | -$875.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $177.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $343.00K 10-Q · filed 2020-07-29 | -$639.00K derived: sum of 3 quarters · filed 2021-02-25 | $205.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $166.00K 10-Q · filed 2020-04-29 | -$816.00K derived: sum of 2 quarters · filed 2021-02-25 | $28.00K derived: sum of 3 quarters · filed 2021-02-25 | $191.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$982.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$138.00K derived: sum of 2 quarters · filed 2021-02-25 | $25.00K derived: sum of 3 quarters · filed 2021-02-25 | -$1.68M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $844.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $1.01M derived: sum of 2 quarters · filed 2019-10-30 | -$695.00K 10-Q · filed 2019-10-30 | -$170.00K derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$1.54M 10-Q · filed 2019-07-24 | -$1.01M derived: sum of 3 quarters · filed 2020-02-19 | -$1.86M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-03-31 | -$1.70M 10-Q · filed 2019-05-01 | -$1.18M derived: sum of 2 quarters · filed 2020-02-19 | -$2.02M derived: sum of 3 quarters · filed 2020-02-19 | -$2.54M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2017-12-31 | $525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$323.00K derived: sum of 2 quarters · filed 2020-02-19 | -$833.00K derived: sum of 3 quarters · filed 2020-02-19 | -$81.00K 10-K · filed 2020-02-19 | |
| 2017-09-30 | -$848.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$1.36M derived: sum of 2 quarters · filed 2018-10-31 | -$606.00K 10-Q · filed 2018-10-31 | -$550.00K derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-06-30 | -$510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $242.00K 10-Q · filed 2018-07-26 | $298.00K derived: sum of 3 quarters · filed 2019-02-19 | $1.15M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-03-31 | $752.00K 10-Q · filed 2018-05-04 | $808.00K derived: sum of 2 quarters · filed 2019-02-19 | $1.66M derived: sum of 3 quarters · filed 2019-02-19 | $1.65M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2016-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $903.00K derived: sum of 2 quarters · filed 2019-02-19 | $901.00K derived: sum of 3 quarters · filed 2019-02-19 | $276.00K 10-K · filed 2019-02-19 | |
| 2016-09-30 | $847.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $845.00K derived: sum of 2 quarters · filed 2017-11-03 | $220.00K 10-Q · filed 2017-11-03 | $346.00K derived: sum of 4 quarters · filed 2018-02-23 | |
| 2016-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$627.00K 10-Q · filed 2017-08-08 | -$501.00K derived: sum of 3 quarters · filed 2018-02-23 | $357.00K derived: sum of 4 quarters · filed 2018-02-23 | |
| 2016-03-31 | -$625.00K 10-Q · filed 2017-05-05 | -$499.00K derived: sum of 2 quarters · filed 2018-02-23 | $359.00K derived: sum of 3 quarters · filed 2018-02-23 | $166.00K derived: sum of 4 quarters · filed 2018-02-23 | |
| 2015-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $984.00K derived: sum of 2 quarters · filed 2018-02-23 | $791.00K derived: sum of 3 quarters · filed 2018-02-23 | -$725.00K 10-K · filed 2018-02-23 | |
| 2015-09-30 | $858.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $665.00K derived: sum of 2 quarters · filed 2016-11-03 | -$851.00K 10-Q · filed 2016-11-03 | -$1.41M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-06-30 | -$193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$1.71M 10-Q · filed 2016-08-04 | -$2.27M derived: sum of 3 quarters · filed 2017-02-28 | -$4.07M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-03-31 | -$1.52M 10-Q · filed 2016-05-05 | -$2.08M derived: sum of 2 quarters · filed 2017-02-28 | -$3.88M derived: sum of 3 quarters · filed 2017-02-28 | -$6.46M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2014-12-31 | -$562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$2.37M derived: sum of 2 quarters · filed 2017-02-28 | -$4.94M derived: sum of 3 quarters · filed 2017-02-28 | -$491.00K 10-K · filed 2017-02-28 | |
| 2014-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$4.38M derived: sum of 2 quarters · filed 2015-11-05 | $71.00K 10-Q · filed 2015-11-05 | $1.45M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-06-30 | -$2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.87M 10-Q · filed 2015-08-06 | $3.25M derived: sum of 3 quarters · filed 2016-02-24 | $4.78M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-03-31 | $4.45M 10-Q · filed 2015-05-08 | $5.83M derived: sum of 2 quarters · filed 2016-02-24 | $7.36M derived: sum of 3 quarters · filed 2016-02-24 | $13.47M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2013-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $2.91M derived: sum of 2 quarters · filed 2016-02-24 | $9.03M derived: sum of 3 quarters · filed 2016-02-24 | $5.85M 10-K · filed 2016-02-24 | |
| 2013-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $7.65M derived: sum of 2 quarters · filed 2014-11-04 | $4.47M 10-Q · filed 2014-11-04 | $6.54M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-06-30 | $6.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.94M 10-Q · filed 2014-08-07 | $5.01M derived: sum of 3 quarters · filed 2015-02-27 | $7.07M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-03-31 | -$3.18M 10-Q · filed 2014-05-07 | -$1.10M derived: sum of 2 quarters · filed 2015-02-27 | $951.00K derived: sum of 3 quarters · filed 2015-02-27 | $358.00K derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $4.13M derived: sum of 2 quarters · filed 2015-02-27 | $3.53M derived: sum of 3 quarters · filed 2015-02-27 | -$1.83M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $1.46M derived: sum of 2 quarters · filed 2013-11-01 | -$3.90M 10-Q · filed 2013-11-01 | $1.90M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2012-06-30 | -$593.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$5.96M 10-Q · filed 2013-08-01 | -$153.00K derived: sum of 3 quarters · filed 2014-03-03 | $2.66M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2012-03-31 | -$5.36M 10-Q · filed 2013-05-01 | -$6.66M 10-Q · filed 2012-05-02 | $440.00K derived: sum of 2 quarters · filed 2014-03-03 | $3.25M derived: sum of 3 quarters · filed 2014-03-03 | $5.79M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $8.61M derived: sum of 2 quarters · filed 2014-03-03 | $11.15M derived: sum of 3 quarters · filed 2014-03-03 | $5.12M 10-K · filed 2014-03-03 | |
| 2011-09-30 | $2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $5.35M derived: sum of 2 quarters · filed 2012-10-31 | -$679.00K 10-Q · filed 2012-10-31 | $4.23M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | -$3.49M 10-Q · filed 2012-08-01 | $1.42M derived: sum of 3 quarters · filed 2013-02-26 | $1.40M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-03-31 | -$6.03M 10-Q · filed 2012-05-02 | -$1.13M derived: sum of 2 quarters · filed 2013-02-26 | -$1.14M derived: sum of 3 quarters · filed 2013-02-26 | ||
| 2010-12-31 | $4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $4.89M derived: sum of 2 quarters · filed 2013-02-26 | $3.32M 10-K · filed 2013-02-26 | ||
| 2010-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$1.58M 10-Q · filed 2011-11-02 | |||
| 2010-06-30 | -$1.57M 10-Q · filed 2011-08-03 | ||||
| 2009-12-31 | -$3.69M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |